| Literature DB >> 20967517 |
Hee Jin Kim1, Moon Jin Kim, Min Jeong Lee, Jong-Hwa Ahn, Ho-Su Kim, In-Suk Kim, Jong Sil Lee, Gyeong-Won Lee.
Abstract
A 61-year-old man was diagnosed with the simultaneous occurrence of chronic myeloid leukemia (CML) and infiltrative intrathoracic plasmacytoma, radiologically mimicking bronchogenic carcinoma. Following the administration of imatinib mesylate (IM; 400 mg/day), both hematologic and partial cytogenetic remission of CML were achieved. However, the pulmonary plasmacytoma was persistently aggravated. High-dose dexamethasone was added to the IM therapy because the patient refused radiotherapy to control the aggravated pulmonary plasmacytoma. Finally, he died due to pneumonia and multi-organ failure during concurrent administration of IM and high-dose dexamethasone.Entities:
Mesh:
Year: 2010 PMID: 20967517 DOI: 10.1007/s12185-010-0705-7
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490